Immune cells take aim at pancreatic cancer in early trial
NCT ID NCT03192462
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 25 times
Summary
This study tested a new experimental therapy using special immune cells (T cells) trained to attack five proteins found on pancreatic cancer cells. It included 37 patients whose cancer had returned, not gone away, or who could not have standard chemo. The main goals were to see if the treatment was safe and if patients could complete all six infusions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor Clinic
Houston, Texas, 77030, United States
-
Harris Health System - Smith Clinic
Houston, Texas, 77054, United States
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.